Skip to main content
Top
Published in: Current Heart Failure Reports 2/2014

01-06-2014 | Management of Heart Failure (TE Meyer, Section Editor)

Decision-Making Under Uncertainty in Advanced Heart Failure

Authors: Theo E. Meyer, Michael S. Kiernan, David D. McManus, Jeffrey Shih

Published in: Current Heart Failure Reports | Issue 2/2014

Login to get access

Abstract

The challenges managing advanced heart failure (AHF) are mounting, not least by the presence of multiple coexisting comorbidities, the lack of evidence of clinical benefit in many subsets of AHF, but also surrounding the uncertainty of the both short-term and long-term prognosis. Clinicians are highly variable in their interpretation of clinical data and are prone to considerable bias when it comes to treatment recommendations. This manuscript provides a critical appraisal of the uncertainties as it pertains to the natural history of AHF and management decisions. First, clinical examples are explored to illustrate common errors of judgment due to unrecognized biases. Secondly, a tool is provided that promulgates a structured approach to key data elements in an attempt to create a sound platform for decision-making.
Literature
1.••
go back to reference Allen LA, Stevenson LW, Grady KL, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125(15):1928–52. This manuscript provides a comprehensive review of the challenges surrounding management decisions for patients with AHF. It is essential reading for all clinicians involved the care with end-stage heart failure. This scientific statement from the AHA provides a thoughtful approach to engage patients and their families during the unpredictable and non-linear course of AHF.PubMedCentralPubMedCrossRef Allen LA, Stevenson LW, Grady KL, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125(15):1928–52. This manuscript provides a comprehensive review of the challenges surrounding management decisions for patients with AHF. It is essential reading for all clinicians involved the care with end-stage heart failure. This scientific statement from the AHA provides a thoughtful approach to engage patients and their families during the unpredictable and non-linear course of AHF.PubMedCentralPubMedCrossRef
2.
go back to reference Tricoci P, Allen JM, Kramer JM, Califf RM, Smith Jr SC. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009;301(8):831–41.PubMedCrossRef Tricoci P, Allen JM, Kramer JM, Califf RM, Smith Jr SC. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009;301(8):831–41.PubMedCrossRef
3.
go back to reference Bland AR, Schaefer A. Different varieties of uncertainty in human decision-making. Front Neurosci. 2012;6:1–11.CrossRef Bland AR, Schaefer A. Different varieties of uncertainty in human decision-making. Front Neurosci. 2012;6:1–11.CrossRef
4.•
go back to reference Loh JC, Creaser J, Rourke DA, Livingston N, et al. Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center. Circ Heart Fail. 2013;6(3):411–9. This manuscript provides contemporary real world data about the impact of modern treatments on outcomes in the patients with a reduced ejection fraction.PubMedCentralPubMedCrossRef Loh JC, Creaser J, Rourke DA, Livingston N, et al. Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993-2010: findings from a university referral center. Circ Heart Fail. 2013;6(3):411–9. This manuscript provides contemporary real world data about the impact of modern treatments on outcomes in the patients with a reduced ejection fraction.PubMedCentralPubMedCrossRef
5.••
go back to reference Alba AC, Agoritsas T, Jankowski M, Courvoisier D, et al. Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review. Circ Heart Fail. 2013;6(5):881–9. This manuscript provides a systematic review of risk prediction models in ambulatory patients with heart failure. The data showed that not one model has been validated that exhibits consistent discrimination between those patients who will experience an adverse outcome versus those who do not, or reliable calibration of the likelihood of an outcome across all levels of risk.PubMedCrossRef Alba AC, Agoritsas T, Jankowski M, Courvoisier D, et al. Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review. Circ Heart Fail. 2013;6(5):881–9. This manuscript provides a systematic review of risk prediction models in ambulatory patients with heart failure. The data showed that not one model has been validated that exhibits consistent discrimination between those patients who will experience an adverse outcome versus those who do not, or reliable calibration of the likelihood of an outcome across all levels of risk.PubMedCrossRef
6.
go back to reference Chen C, Stevenson L, Stewart GC, et al. Impact of baseline heart failure burden on post-implantable cardioverter-defibrillator mortality among medicare beneficiaries. J Am Coll Cardiol. 2013;61(21):2142–50.PubMedCrossRef Chen C, Stevenson L, Stewart GC, et al. Impact of baseline heart failure burden on post-implantable cardioverter-defibrillator mortality among medicare beneficiaries. J Am Coll Cardiol. 2013;61(21):2142–50.PubMedCrossRef
7.
go back to reference Habal MV, Liu PP, Austin PC, et al. Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure. Circ Heart Fail. 2014;7(1):12–20.PubMedCrossRef Habal MV, Liu PP, Austin PC, et al. Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure. Circ Heart Fail. 2014;7(1):12–20.PubMedCrossRef
8.
go back to reference Cleland JG, Chiswell K, Teerlink JR, et al. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the placebo-controlled randomized study of the selective A1 Adenosine Receptor antagonist Rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function (PROTECT) study. Circ Heart Fail. 2014;7(1):76–87.PubMedCrossRef Cleland JG, Chiswell K, Teerlink JR, et al. Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the placebo-controlled randomized study of the selective A1 Adenosine Receptor antagonist Rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function (PROTECT) study. Circ Heart Fail. 2014;7(1):76–87.PubMedCrossRef
9.
go back to reference Madan VD, Novak E, Rich MW. Impact of change in serum sodium concentration on mortality in patients hospitalized with heart failure and hyponatremia. Circ Heart Fail. 2011;4(5):637–43.PubMedCrossRef Madan VD, Novak E, Rich MW. Impact of change in serum sodium concentration on mortality in patients hospitalized with heart failure and hyponatremia. Circ Heart Fail. 2011;4(5):637–43.PubMedCrossRef
10.
go back to reference Kittleson M, Hurwitz S, Shah MR, et al. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. J Am Coll Cardiol. 2003;41(11):2029–35.PubMedCrossRef Kittleson M, Hurwitz S, Shah MR, et al. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. J Am Coll Cardiol. 2003;41(11):2029–35.PubMedCrossRef
11.
go back to reference Alba AC, Braga J, Gewarges M, Walter SD, Guyatt GH, Ross HJ. Predictors of mortality in patients with an implantable cardiac defibrillator: a systematic review and meta-analysis. Can J Cardiol. 2013;29(12):1729–40.PubMedCrossRef Alba AC, Braga J, Gewarges M, Walter SD, Guyatt GH, Ross HJ. Predictors of mortality in patients with an implantable cardiac defibrillator: a systematic review and meta-analysis. Can J Cardiol. 2013;29(12):1729–40.PubMedCrossRef
12.
go back to reference Powell BD, Saxon LA, Boehmer JP, et al. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol. 2013;62(18):1674–9.PubMedCrossRef Powell BD, Saxon LA, Boehmer JP, et al. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol. 2013;62(18):1674–9.PubMedCrossRef
13.
go back to reference Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050–3.PubMedCrossRef Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050–3.PubMedCrossRef
14.
go back to reference Yamokoski LM, Hasselblad V, Moser DK, et al. Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trial. J Card Fail. 2007;13:8–13.PubMedCrossRef Yamokoski LM, Hasselblad V, Moser DK, et al. Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trial. J Card Fail. 2007;13:8–13.PubMedCrossRef
15.
go back to reference Allen LA, Yager JE, Funk MJ, et al. Discordance between patient predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA. 2008;299(21):2533–42.PubMedCentralPubMedCrossRef Allen LA, Yager JE, Funk MJ, et al. Discordance between patient predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA. 2008;299(21):2533–42.PubMedCentralPubMedCrossRef
16.
go back to reference Hauptman PJ, Swindle J, Hussain Z, et al. Physician attitudes toward end-stage heart failure: a national survey. Am J Med. 2008;121:127–35.PubMedCrossRef Hauptman PJ, Swindle J, Hussain Z, et al. Physician attitudes toward end-stage heart failure: a national survey. Am J Med. 2008;121:127–35.PubMedCrossRef
17.
go back to reference Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–220.PubMedCrossRef Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–220.PubMedCrossRef
18.
go back to reference Baltes P. Extending longevity: dignity gain – or dignity drain? Max Planck Res. 2003;3:15–9. Baltes P. Extending longevity: dignity gain – or dignity drain? Max Planck Res. 2003;3:15–9.
19.
go back to reference Ahluwalia SC, Gross CP, Chaudhry SI, et al. Change in comorbidity prevalence with advancing age among persons with heart failure. J Gen Intern Med. 2011;26(10):1145–51.PubMedCentralPubMedCrossRef Ahluwalia SC, Gross CP, Chaudhry SI, et al. Change in comorbidity prevalence with advancing age among persons with heart failure. J Gen Intern Med. 2011;26(10):1145–51.PubMedCentralPubMedCrossRef
20.
go back to reference U.S. Renal Data System, USRDS 2013 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2013. U.S. Renal Data System, USRDS 2013 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2013.
21.
go back to reference Banerjee D, Ma JZ, Collins AJ, Herzog CA. Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload. Clin J Am Soc Nephrol. 2007;2(6):1186–90.PubMedCrossRef Banerjee D, Ma JZ, Collins AJ, Herzog CA. Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload. Clin J Am Soc Nephrol. 2007;2(6):1186–90.PubMedCrossRef
22.
go back to reference Herzog CA, Li S, Weinhandl ED, et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardiac defibrillators. Kidney Int. 2005;68(2):818–25.PubMed Herzog CA, Li S, Weinhandl ED, et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardiac defibrillators. Kidney Int. 2005;68(2):818–25.PubMed
23.
go back to reference GOLD Global Initiative for Chronic Obstructive Lung Disease Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: NHLBI/WHO Workshop Report Updated 2008. http://www.goldcopd.com. GOLD Global Initiative for Chronic Obstructive Lung Disease Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: NHLBI/WHO Workshop Report Updated 2008. http://​www.​goldcopd.​com.
24.
go back to reference Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.PubMedCrossRef Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.PubMedCrossRef
25.
go back to reference Breen D, Churches T, Hawker F, Torzillo PJ. Acute respiratory failure secondary to chronic obstructive pulmonary disease treated in the intensive care unit: a long term follow up study. Thorax. 2002;57(1):29–33.PubMedCentralPubMedCrossRef Breen D, Churches T, Hawker F, Torzillo PJ. Acute respiratory failure secondary to chronic obstructive pulmonary disease treated in the intensive care unit: a long term follow up study. Thorax. 2002;57(1):29–33.PubMedCentralPubMedCrossRef
26.
go back to reference Nathaniel MH, Petrie MC, et al. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11(2):130–9.CrossRef Nathaniel MH, Petrie MC, et al. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11(2):130–9.CrossRef
27.
go back to reference Nathaniel MH, Virani S, Ceconi C. Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services. Eur Heart J. 2013;34(36):2795–807.CrossRef Nathaniel MH, Virani S, Ceconi C. Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services. Eur Heart J. 2013;34(36):2795–807.CrossRef
28.
go back to reference De Blois J, Simard S, Atar D, Agewall S, Norwegian Heart Failure Registry. COPD predicts mortality in HF: the Norwegian Heart Failure Registry. J Card Fail. 2010;16(3):225–9.PubMedCrossRef De Blois J, Simard S, Atar D, Agewall S, Norwegian Heart Failure Registry. COPD predicts mortality in HF: the Norwegian Heart Failure Registry. J Card Fail. 2010;16(3):225–9.PubMedCrossRef
29.
go back to reference Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326(6):381–6.PubMedCrossRef Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326(6):381–6.PubMedCrossRef
30.
go back to reference Feringa HH, Bax JJ, Hoeks S, et al. A prognostic risk index for long-term mortality in patients with peripheral arterial disease. Arch Intern Med. 2007;167(22):2482–9.PubMedCrossRef Feringa HH, Bax JJ, Hoeks S, et al. A prognostic risk index for long-term mortality in patients with peripheral arterial disease. Arch Intern Med. 2007;167(22):2482–9.PubMedCrossRef
31.
go back to reference Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52:1111–21.PubMedCrossRef Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52:1111–21.PubMedCrossRef
32.
go back to reference Gregoratos G, Abrams J, Epstein AE, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation. 2002;106:2145–61.PubMedCrossRef Gregoratos G, Abrams J, Epstein AE, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation. 2002;106:2145–61.PubMedCrossRef
33.
go back to reference Parkash R, Sapp JL, Basta M, et al. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit. Circ Arrhythm Electrophysiol. 2012;5(4):706–13.PubMedCrossRef Parkash R, Sapp JL, Basta M, et al. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit. Circ Arrhythm Electrophysiol. 2012;5(4):706–13.PubMedCrossRef
34.
go back to reference Santangeli P, Di Biase L, Dello Russo A, et al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann Intern Med. 2010;153(9):592–9.PubMedCrossRef Santangeli P, Di Biase L, Dello Russo A, et al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann Intern Med. 2010;153(9):592–9.PubMedCrossRef
35.
go back to reference Korantzopoulos P, Liu T, Li L, Goudevenos JA, Li G. Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis. Europace. 2009;11(11):1469–75.PubMedCrossRef Korantzopoulos P, Liu T, Li L, Goudevenos JA, Li G. Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis. Europace. 2009;11(11):1469–75.PubMedCrossRef
36.
go back to reference Amin MS, Fox AD, Kalahasty G, Shepard RK, Wood MA, Ellenbogen KA. Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis. J Cardiovasc Electrophysiol. 2008;19(12):1275–80.PubMedCrossRef Amin MS, Fox AD, Kalahasty G, Shepard RK, Wood MA, Ellenbogen KA. Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis. J Cardiovasc Electrophysiol. 2008;19(12):1275–80.PubMedCrossRef
37.••
go back to reference Hauptman PJ, Chibnall JT, Guild C, Armbrecht ES. Patient perceptions, physician communication, and the implantable cardioverter-defibrillator. JAMA. 2013;173(7):571–7. This sobering analysis by Hauptman and colleagues underscores both the lack of patient understanding of the impact and purpose of ICD’s on the natural history of HF, and the paucity of physician-driven communication about these issues. Hauptman PJ, Chibnall JT, Guild C, Armbrecht ES. Patient perceptions, physician communication, and the implantable cardioverter-defibrillator. JAMA. 2013;173(7):571–7. This sobering analysis by Hauptman and colleagues underscores both the lack of patient understanding of the impact and purpose of ICD’s on the natural history of HF, and the paucity of physician-driven communication about these issues.
38.
go back to reference Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA, et al. Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States. Circ Cardiovasc Qual Outcomes. 2011;4(5):549–56.PubMedCrossRef Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA, et al. Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States. Circ Cardiovasc Qual Outcomes. 2011;4(5):549–56.PubMedCrossRef
39.
go back to reference Krahn AD, Lee DS, Birnie D, et al. Ontario ICD Database Investigators. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol. 2011;4(2):136–42.PubMedCrossRef Krahn AD, Lee DS, Birnie D, et al. Ontario ICD Database Investigators. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol. 2011;4(2):136–42.PubMedCrossRef
40.
go back to reference Linde C, Ellenbogen K, McAlister FA. Cardiac resynchronization therapy (CRT): clinical trials, guidelines, and target populations. Heart Rhythm. 2012;9(8 Suppl):S3–13.PubMedCrossRef Linde C, Ellenbogen K, McAlister FA. Cardiac resynchronization therapy (CRT): clinical trials, guidelines, and target populations. Heart Rhythm. 2012;9(8 Suppl):S3–13.PubMedCrossRef
41.
go back to reference Harris R. Introduction to decision making, Part 1. VirtualSalt. 22. Harris R. Introduction to decision making, Part 1. VirtualSalt. 22.
42.
go back to reference Kaplan RM, Frosch DL. Decision making in medicine and health care. Annu Rev Clin Psychol. 2005;1:525–56.PubMedCrossRef Kaplan RM, Frosch DL. Decision making in medicine and health care. Annu Rev Clin Psychol. 2005;1:525–56.PubMedCrossRef
43.•
go back to reference Shaw D, Elger B. Evidence-based persuasion: an ethical imperative. JAMA. 2013;309(16):1689–90. The authors make a cogent case for evidence persuasion in the era of patient autonomy.PubMedCrossRef Shaw D, Elger B. Evidence-based persuasion: an ethical imperative. JAMA. 2013;309(16):1689–90. The authors make a cogent case for evidence persuasion in the era of patient autonomy.PubMedCrossRef
44.••
go back to reference Kahneman D. Thinking, fast and slow. Macmillan. 2011. ISBN 978-1-4299-6935-2. Retrieved 8 April 2012. This fascinating book highlights the basis of the human thinking processes and explores the underpinnings of unrecognized biases during judgment under uncertainty. Kahneman D. Thinking, fast and slow. Macmillan. 2011. ISBN 978-1-4299-6935-2. Retrieved 8 April 2012. This fascinating book highlights the basis of the human thinking processes and explores the underpinnings of unrecognized biases during judgment under uncertainty.
45.••
go back to reference Hammond JS, Keeney RL, Raiffa H. Smart choices: a practical guide to making better life decisions. Broadway Books ISBN: 0-7679-0886-4. 2002. This popular book provides a simple and straightforward framework to break decisions down to manageable elements. It further provides a tool that can be used for complex decision-making. Hammond JS, Keeney RL, Raiffa H. Smart choices: a practical guide to making better life decisions. Broadway Books ISBN: 0-7679-0886-4. 2002. This popular book provides a simple and straightforward framework to break decisions down to manageable elements. It further provides a tool that can be used for complex decision-making.
Metadata
Title
Decision-Making Under Uncertainty in Advanced Heart Failure
Authors
Theo E. Meyer
Michael S. Kiernan
David D. McManus
Jeffrey Shih
Publication date
01-06-2014
Publisher
Springer US
Published in
Current Heart Failure Reports / Issue 2/2014
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-014-0195-7

Other articles of this Issue 2/2014

Current Heart Failure Reports 2/2014 Go to the issue

Management of Heart Failure (TE Meyer, Section Editor)

Polypharmacy in Heart Failure Patients

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section Editor)

Heart Failure and Obesity in Adults: Pathophysiology, Clinical Manifestations and Management

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section Editor)

Interleukin-6 Signaling, Soluble Glycoprotein 130, and Inflammation in Heart Failure

Management of Heart Failure (TE Meyer, Section Editor)

Determinants of Survival Following Hospitalization for Acute Heart Failure

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section Editor)

Neuregulin-1 Signaling in the Pathogenesis of Chemotherapy-Induced Heart Failure

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.